149 related articles for article (PubMed ID: 36965231)
21. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature.
Wakim JJ; Tirado CA; Chen W; Collins R
Leuk Res; 2011 Sep; 35(9):e151-3. PubMed ID: 21628071
[No Abstract] [Full Text] [Related]
22. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature.
Kumar KR; Chen W; Koduru PR; Luu HS
Am J Clin Pathol; 2015 May; 143(5):738-48. PubMed ID: 25873510
[TBL] [Abstract][Full Text] [Related]
23. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia.
Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK
Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic fusion protein BCR-FGFR1 requires the breakpoint cluster region-mediated oligomerization and chaperonin Hsp90 for activation.
Peiris MN; Meyer AN; Nelson KN; Bisom-Rapp EW; Donoghue DJ
Haematologica; 2020 May; 105(5):1262-1273. PubMed ID: 31439673
[TBL] [Abstract][Full Text] [Related]
25. A chronic myelogenous leukemia-like myeloproliferative disorder accompanied by T-cell lymphoblastic lymphoma with chromosome translocation t(8;13)(p11;q12): a Japanese case.
Matsumoto K; Morita K; Takada S; Sakura T; Shiozaki H; Murakami H; Miyawaki S
Int J Hematol; 1999 Dec; 70(4):278-82. PubMed ID: 10643154
[TBL] [Abstract][Full Text] [Related]
26. Identification of four new translocations involving FGFR1 in myeloid disorders.
Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
[TBL] [Abstract][Full Text] [Related]
27. 8p11 Myeloproliferative syndrome with t(8;22)(p11;q11): A case report.
Liu JJ; Meng L
Exp Ther Med; 2018 Aug; 16(2):1449-1453. PubMed ID: 30116393
[TBL] [Abstract][Full Text] [Related]
28. FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case report.
Chang K; Liu JH; Yu SC; Lin CW
Hum Pathol; 2018 Apr; 74():114-121. PubMed ID: 29107667
[TBL] [Abstract][Full Text] [Related]
29. Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogeneous leukemia.
Richebourg S; Theisen O; Plantier I; Parry A; Soenen-Cornu V; Lepelley P; Preudhomme C; Renneville A; Laï JL; Roche-Lestienne C
Genes Chromosomes Cancer; 2008 Oct; 47(10):915-8. PubMed ID: 18615682
[No Abstract] [Full Text] [Related]
30. Remarkably long survival of a patient with Ph1-positive chronic myeloid leukemia and 5' bcr rearrangement.
Johansson B; Mertens F; Fioretos T; Heim S; Kristoffersson U; Mandahl N; Bartram CR; Mitelman F
Leukemia; 1990 Jun; 4(6):448-9. PubMed ID: 2359344
[TBL] [Abstract][Full Text] [Related]
31. Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.
Duckworth CB; Zhang L; Li S
Int J Clin Exp Pathol; 2014; 7(2):801-7. PubMed ID: 24551307
[TBL] [Abstract][Full Text] [Related]
32. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
Park TS; Song J; Kim JS; Yang WI; Song S; Kim SJ; Suh B; Choi JR
Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660
[TBL] [Abstract][Full Text] [Related]
33. A case of acute myelogenous leukaemia characterised by the BCR-FGFR1 translocation.
Matikas A; Tzannou I; Oikonomopoulou D; Bakiri M
BMJ Case Rep; 2013 Mar; 2013():. PubMed ID: 23519513
[TBL] [Abstract][Full Text] [Related]
34. Chronic myelogenous leukemia-like hematological malignancy with t(8;22) in a 26-year-old pregnant woman: A case report.
Qin YW; Yang YN; Bai P; Wang C
Oncol Lett; 2016 Jun; 11(6):4131-4133. PubMed ID: 27313753
[TBL] [Abstract][Full Text] [Related]
35. 8p11 myeloproliferative syndrome with t(1;8)(q25;p11.2): a case report and review of the literature.
Kim WS; Park SG; Park G; Jang SJ; Moon DS; Kang SH
Acta Haematol; 2015; 133(1):101-5. PubMed ID: 25227135
[TBL] [Abstract][Full Text] [Related]
36. Myeloid/lymphoid neoplasm with a novel cryptic
Yang T; Mahmood N; Goldberg B; Cevallos J; Hsu P; Kolitz J; Cohen N; Zhang X
Leuk Lymphoma; 2023 Dec; 64(14):2338-2342. PubMed ID: 37791611
[No Abstract] [Full Text] [Related]
37. Pemigatinib for the treatment of myeloid/lymphoid neoplasms with
Freyer CW; Hughes ME; Carulli A; Bagg A; Hexner E
Expert Rev Anticancer Ther; 2023 Apr; 23(4):351-359. PubMed ID: 36927350
[TBL] [Abstract][Full Text] [Related]
38. Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and
Yan Y; Qu S; Liu J; Li C; Yan X; Xu Z; Qin T; Jia Y; Pan L; Gao Q; Jiao M; Li B; Gale RP; Xiao Z
Leuk Lymphoma; 2023 Sep; 64(9):1605-1610. PubMed ID: 37354441
[No Abstract] [Full Text] [Related]
39. A rare cause of persistent leukocytosis with massive splenomegaly: Myeloid neoplasm with BCR-PDGFRA rearrangement-Case report and literature review.
Gao L; Xu Y; Weng LC; Tian ZG
Medicine (Baltimore); 2022 Jun; 101(24):e29179. PubMed ID: 35713428
[TBL] [Abstract][Full Text] [Related]
40. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
Landberg N; Dreimane A; Rissler M; Billström R; Ågerstam H
Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
